Physician profile
Varun Avula
NPI 1356754949
$36,188.09
in general payments reported to CMS, 2019-2025
41 companies · $7,223 in 2025
The $7,223 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.74 · 2020: $1,262 · 2021: $2,384 · 2022: $2,832 · 2023: $6,041 · 2024: $16K · 2025: $7,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $8,966 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,027.73 |
| Travel and Lodging | $8,965.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,383.68 | 2021-2025 | Corevalve Evolut R |
| Shockwave Medical, INC | $7,849.81 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $3,658.33 | 2020-2025 | General - Therapies, Watchman Access System, Watchman |
| Edwards Lifesciences Corporation | $2,577.13 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,639.53 | 2022-2025 | Impella |
| Inari Medical, INC. | $1,117.35 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $844.94 | 2023-2025 | Amplatzer Amulet, Cardiomems, Viewmate |
| Stryker Corporation | $582.55 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Astrazeneca Pharmaceuticals LP | $446.10 | 2020-2025 | Farxiga, Brilinta, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.81 | 2022-2025 | Lifevest |
| Heartflow, INC. | $383.98 | 2022-2025 | Ffrct |
| Pfizer INC. | $301.59 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.74 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $179.76 | 2023-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $159.64 | 2021-2024 | Xarelto |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Avula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.